KURE Holdings Information

KURE is an equity ETF with a total of 49 individual holdings. The top holdings are Innovent Biologics stock at 8.82%, BeOne Medicines AG at 8.42%, WuXi Biologics at 6.62%, Akeso at 5.84%, and WuXi AppTec at 5.64%.

Total Holdings

Top 10 Percentage

55.46%

Asset Class

Equity

ETF Category

China Region

Assets

85.30M

PE Ratio

26.60

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	HKG: 1801	Innovent Biologics, Inc.	8.82%	645,000
2	HKG: 6160	BeOne Medicines AG	8.42%	300,318
3	HKG: 2269	WuXi Biologics (Cayman) Inc.	6.62%	1,266,135
4	HKG: 9926	Akeso, Inc.	5.84%	278,000
5	SHA: 603259	WuXi AppTec Co., Ltd.	5.64%	321,720
6	SHA: 600276	Jiangsu Hengrui Pharmaceuticals Co.,Ltd	4.50%	461,108
7	HKG: 1177	Sino Biopharmaceutical Limited	4.24%	4,475,750
8	SHE: 300760	Shenzhen Mindray Bio-Medical Electronics Co., Ltd.	3.99%	144,555
9	HKG: 3692	Hansoh Pharmaceutical Group Company Limited	3.75%	638,000
10	HKG: 1093	CSPC Pharmaceutical Group Limited	3.63%	2,500,889
11	HKG: 2359	WuXi AppTec Co., Ltd.	3.13%	167,584
12	HKG: 1530	3SBio Inc.	3.04%	801,500
13	SHE: 000538	Yunnan Baiyao Group Co.,Ltd	2.16%	224,023
14	SHA: 688271	Shanghai United Imaging Healthcare Co., Ltd.	2.09%	107,071
15	SHA: 600436	Zhangzhou Pientzehuang Pharmaceutical., Ltd	1.98%	76,434
16	SHE: 300015	Aier Eye Hospital Group Co., Ltd.	1.93%	1,176,763
17	HKG: 1099	Sinopharm Group Co. Ltd.	1.80%	576,400
18	SHE: 002294	Shenzhen Salubris Pharmaceuticals Co., Ltd.	1.68%	145,065
19	HKG: 6990	Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.	1.61%	21,400
20	REGMF	RemeGen Co Ltd Class H	1.40%	81,000
21	SHE: 000963	Huadong Medicine Co., Ltd	1.39%	221,041
22	HKG: 2268	WuXi XDC Cayman Inc.	1.32%	144,000
23	SHE: 002422	Sichuan Kelun Pharmaceutical Co., Ltd.	1.25%	203,015
24	SHA: 600196	Shanghai Fosun Pharmaceutical (Group) Co., Ltd.	1.22%	264,329
25	SHE: 002653	Haisco Pharmaceutical Group Co., Ltd.	1.17%	118,600

Showing 25 of 49 holdings

Subscribe to see the full list

Activate Now

As of Apr 2, 2026